This highly qualified expert has years of experience in the field of neuropharmacology. He received his PhD degree from the University of California, Santa Barbara, and completed his fellowship training at Harvard University. He is a member of various professional associations, including the American Society of Pharmacology and Experimental Therapeutics and the American Chemical Society. He has published 250+ peer reviewed journal articles and has 51+ US issued patents that focus particularly on neurological studies. He also serves as the editor-in-chief for ACS Chemical Neuroscience, lectures both nationally and internationally and has received multiple honors for his outstanding work, including the John J. Abel award in pharmacology. He is the former co-director of the Synthesis Facility at the Vanderbilt Institute of Chemical Biology and the former senior organic chemist at Eli Lilly & Co. Currently, he is a professor of pharmacology and chemistry at a major university, where he is also the director of medicinal chemistry and DMPK at the Center for Neuroscience Drug Discovery. Additionally, he is the director of drug discovery at a major science institute in Tennessee.
BS, Chemistry, California State University
PhD, University of California Santa Barbara
Fellowship, Harvard University
Member, American Society of Pharmacology & Experimental Therapeutics
Member, American Chemical Society
Honor, John J. Abel Award in Pharmacology
Published, 250+ Peer-reviewed Journal Articles
Editor-in-Chief, ACS Chemical Neuroscience
Patents, 51+ US Issued Patents
Lecturer & Presenter, Numerous National & International Locations
Former, Co-Director, Synthesis Facility, Vanderbilt Institute of Chemical Biology
Former, Senior Organic Chemist, Eli Lilly & Co.
Current, Professor, Pharmacology & Chemistry, Major University
Current, Director, Medicinal Chemistry & DMPK, Center for Neuroscience Drug Discovery, Major University
Current, Director, Drug Discovery, Major Science Institute